Aquabounty Technologies

Penny Stocks Biotech Stocks Healthcare Stocks

$0.92

+0.05 (+6.23%)

As of Mar 31, 5:01 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 38%

Sell 5 63%

Price Target

Analyst Price Target +2,194.9% upside

Low Target $14.27

Average Target $21.09

High Target $34.90

Current Price $0.92

Current
$0.92

Target
$21.09

$14.27 $21.09 avg $34.90

Scenario Analysis

Bear Case

$14.27

1,452.8%

Low target

Base Case

$21.09

+2,194.9%

Avg target

Bull Case

$34.90

+3,697.6%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$2.95

-68.8% from high

52-Week Low

$0.60

+53.2% from low

Target vs 52W High

$21.09

+614.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%